ASX:AHZ

Admedus Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Admedus (ASX:AHZ) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying AHZ stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Admedus, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Admedus vs. (CHV) Stock

(CHV) (CNSX:CHV) and Admedus (ASX:AHZ) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Profitability

This table compares (CHV) and Admedus' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(CHV)	N/A	N/A	N/A
Admedus	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and recommmendations for (CHV) and Admedus, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(CHV)	0	0	0	0	N/A
Admedus	0	0	0	0	N/A

Valuation and Earnings

This table compares (CHV) and Admedus' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(CHV)	N/A	N/A	N/A	N/A	N/A
Admedus	N/A	N/A	N/A	N/A	N/A

Admedus vs. (DDXS) Stock

Admedus (ASX:AHZ) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Valuation & Earnings

This table compares Admedus and (DDXS)'s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Admedus	N/A	N/A	N/A	N/A	N/A
(DDXS)	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and target prices for Admedus and (DDXS), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Admedus	0	0	0	0	N/A
(DDXS)	0	0	0	0	N/A

Profitability

This table compares Admedus and (DDXS)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Admedus	N/A	N/A	N/A
(DDXS)	N/A	N/A	N/A

Admedus vs. (PREV) Stock

(PREV) (CNSX:PREV) and Admedus (ASX:AHZ) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.

Profitability

This table compares (PREV) and Admedus' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(PREV)	N/A	N/A	N/A
Admedus	N/A	N/A	N/A

Valuation and Earnings

This table compares (PREV) and Admedus' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(PREV)	N/A	N/A	N/A	N/A	N/A
Admedus	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (PREV) and Admedus, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(PREV)	0	0	0	0	N/A
Admedus	0	0	0	0	N/A

Admedus vs. (TNGN) Stock

(TNGN) (OTCMKTS:TNGN) and Admedus (ASX:AHZ) are both health technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Profitability

This table compares (TNGN) and Admedus' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(TNGN)	N/A	N/A	N/A
Admedus	N/A	N/A	N/A

Valuation & Earnings

This table compares (TNGN) and Admedus' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(TNGN)	N/A	N/A	N/A	N/A	N/A
Admedus	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent recommendations for (TNGN) and Admedus, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(TNGN)	0	0	0	0	N/A
Admedus	0	0	0	0	N/A

Admedus vs. 138267 (COM.TO) Stock

138267 (COM.TO) (TSE:COM) and Admedus (ASX:AHZ) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Profitability

This table compares 138267 (COM.TO) and Admedus' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
138267 (COM.TO)	N/A	N/A	N/A
Admedus	N/A	N/A	N/A

Valuation & Earnings

This table compares 138267 (COM.TO) and Admedus' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
138267 (COM.TO)	N/A	N/A	N/A	N/A	N/A
Admedus	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent recommendations for 138267 (COM.TO) and Admedus, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
138267 (COM.TO)	0	0	0	0	N/A
Admedus	0	0	0	0	N/A

Admedus vs. 17031 Stock

17031 (CNSX:MYM) and Admedus (ASX:AHZ) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Profitability

This table compares 17031 and Admedus' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
17031	N/A	N/A	N/A
Admedus	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent recommendations for 17031 and Admedus, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
17031	0	0	0	0	N/A
Admedus	0	0	0	0	N/A

Valuation & Earnings

This table compares 17031 and Admedus' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
17031	N/A	N/A	N/A	N/A	N/A
Admedus	N/A	N/A	N/A	N/A	N/A